The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy-Reference-Cited by-同舟云学术

The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy

Published:2021 Issue:4 Volume:255 Page:303-313
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Miyahara Shuko¹,Tsuji Keita¹,Shimada Muneaki¹,Shibuya Yusuke¹,Shigeta Shogo¹,Nagai Tomoyuki¹,Umezawa Rei¹,Tokunaga Hideki¹,Jingu Keiichi²,Yaegashi Nobuo¹

Affiliation:

1. Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine

2. Department of Radiation Oncology, Tohoku University Graduate School of Medicine

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/255/4/255_303/_pdf

Reference30 articles.

1. Arbyn, M., Weiderpass, E., Bruni, L., de Sanjose, S., Saraiya, M., Ferlay, J. & Bray, F.(2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health, 8, e191-e203.

2. Chen, J.L., Huang, C.Y., Huang, Y.S., Chen, R.J., Wang, C.W., Chen, Y.H., Cheng, J.C., Cheng, A.L. & Kuo, S.H.(2014) Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy. Acta Obstet. Gynecol. Scand., 93, 661-668.

3. Duenas-Gonzalez, A., Zarba, J.J., Patel, F., Alcedo, J.C., Beslija, S., Casanova, L., Pattaranutaporn, P., Hameed, S., Blair, J.M., Barraclough, H. & Orlando, M.(2011) Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J. Clin. Oncol., 29, 1678-1685.

4. Ebina, Y., Mikami, M., Nagase, S., Tabata, T., Kaneuchi, M., Tashiro, H., Mandai, M., Enomoto, T., Kobayashi, Y., Katabuchi, H., Yaegashi, N., Udagawa, Y. & Aoki, D.(2019) Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer. Int. J. Clin. Oncol., 24, 1-19.

5. Hu, K., Wang, W., Liu, X., Meng, Q. & Zhang, F.(2018) Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy. Radiat. Oncol., 13, 249.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities;Clinical and Experimental Obstetrics & Gynecology;2023-10-20

2. Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: A multi-center retrospective study;2023-09-25

3. Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study;Scientific Reports;2023-07-25

4. Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution;Brachytherapy;2023-07

5. Predictive value of the number of metastatic lymph nodes and lymph node ratio on the prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study;2023-06-29